Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CBT for insomnia (CBT-I) is considered the first-line treatment for insomnia (557) and outperforms pharmacological interventions, in particular with respect to maintenance of therapeutic effects at long-term follow-up (270, 513).”
From The Sleep-Immune Crosstalk in Health and Disease (2019) · cites this paper as [557]
Citations
Cites
Aspirin Selectively Inhibits Prostaglandin Production in Human Platelets
SMITH, J. B., & WILLIS, A. L. (1971) · Nature New Biology · doi:10.1038/newbio231235a0 · Cited by 1,521
Indomethacin and Aspirin abolish Prostaglandin Release from the Spleen
FERREIRA, S. H., MONCADA, S., & VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231237a0 · Cited by 941
Self-citationProstaglandins: Their Disappearance from and Release into the Circulation
FERREIRA, S. H., & VANE, J. R. (1967) · Nature · doi:10.1038/216868a0 · Cited by 892
Self-citationRelease of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory Drugs
PIPER, P. J., & VANE, J. R. (1969) · Nature · doi:10.1038/223029a0 · Cited by 880
Self-citationA SENSITIVE METHOD FOR THE ASSAY OF 5‐HYDROXYTRYPTAMINE
VANE, J. R. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00146.x · Cited by 772
Self-citationTHE PROSTAGLANDINS: A FAMILY OF BIOLOGICALLY ACTIVE LIPIDS
BERGSTRÖM, S., CARLSON, L. A., & WEEKS, J. R. (1968) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07108-x · Cited by 634
Prostaglandins released by the Spleen
Gilmore, N. J., Vane, J. R., & Wyllie, J. H. (1968) · Nature · doi:10.1038/2181135a0 · Cited by 548
Self-citationProstaglandins and related factors: XIX. Thin-layer chromatography of prostaglandins
Gréen, K., & Samuelsson, B. (1964) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40270-6 · Cited by 476
Cutaneous reactions to intradermal prostaglandins
Crunkhorn, P., & Willis, A. L. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb09934.x · Cited by 348
The enzymic conversion of all‐cis 8,11,14‐eicosatrienoic acid into prostaglandin E1
Nugteren, D. H., Beerthuis, R. K., & van Dorp, D. A. (1966) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19660850412 · Cited by 339
Research works printed but not linked: 11
- Jacques, R., Helv. Physiol. Pharmacol. Acta, 23, 156 (1965).
- Berry, P. A., thesis, Council for National Academic Awards, London, 91 (1966).
- Vargaftig, B. B., and Dao, N., Pharmacology (in the press).
- Piper, P. J., and Vane, J. R., in Prostaglandins (edit. by Ramwell, P., and Shaw, J.) (NY Acad. Sci., in the press, 1971).
- Willis, A. L., Brit. J. Pharmacol., 40, 583P (1970).
- Milton, A. S., and Wendlandt, S. J., J. Physiol., 207, 76P (1970).
- Feldberg, W., and Saxena, P. N., J. Physiol. (in the press, 1971).
- Willis, A. L., in Prostaglandins, Peptides and Amines (edit. by Mantegazza, P., and Horton, E. W.), 31 (Academic Press, London, 1969).
- Collier, H. O. J., Nature (in the press).
- Goodman, L. S., and Gilman, A., The Pharmacological Basis ofTherapeutics, fourth ed. (Collier-Macmillan, London, 1970).
- Hucker, H. B., Zacchei, A. G., Cox, S. V., Brodie, D. A., and Cantwell, N. H. R., J. Pharmac. Exp. Therap., 153, 237 (1966).
Cited by
Items 1,001–1,039 of 1,039
Adventures in vascular biology: a tale of two mediators
Moncada, S. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2005.1775 · Cited by 113
Cyclooxygenase Inhibition as a Strategy to Ameliorate Brain Injury
Hurley, S. D., Olschowka, J. A., & O'Banion, M. K. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753460196 · Cited by 110
Telleria-Diaz, A., Schmidt, M., Kreusch, S., Neubert, A.-K., Schache, F., Vazquez, E., Vanegas, H., Schaible, H.-G., & Ebersberger, A. (2010) · Pain · doi:10.1016/j.pain.2009.08.013 · Cited by 109
Biemond, P., Swaak, A. J., Penders, J. M., Beindorff, C. M., & Koster, J. F. (1986) · Annals of the Rheumatic Diseases · doi:10.1136/ard.45.3.249 · Cited by 108
Cao, C., Matsumura, K., Ozaki, M., & Watanabe, Y. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00716.1999 · Cited by 105
Gao, J., Mfuh, A., Amako, Y., & Woo, C. M. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.7b11639 · Cited by 102
Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides
Hanel, A. M., & Lands, W. E. M. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90565-2 · Cited by 95
Defining the Microglia Response during the Time Course of Chronic Neurodegeneration
Vincenti, J. E., Murphy, L., Grabert, K., McColl, B. W., Cancellotti, E., Freeman, T. C., & Manson, J. C. (2016) · Journal of Virology · doi:10.1128/jvi.02613-15 · Cited by 88
“The latter is known to be expressed in prion disease (90, 91) and is a target of nonsteroidal anti-inflammatory drugs used in clinical trials to treat neurodegenerative diseases by inhibiting prostaglandin synthesis (92).”
Alloui, A., Chassaing, C., Schmidt, J., Ardid, D., Dubray, C., Cloarec, A., & Eschalier, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01578-9 · Cited by 83
Qin, N., Zhang, S.-P., Reitz, T. L., Mei, J. M., & Flores, C. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090944 · Cited by 77
Bonnefont, J., Alloui, A., Chapuy, E., Clottes, E., & Eschalier, A. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00034 · Cited by 74
“result of the peripheral inhibition of the cyclo-oxygenases.(1) In vitro inhibition of cyclo-oxygenase activity was reported, but it has been suggested that inflammation-”
BackgroundAcetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2
Engström Ruud, L., Wilhelms, D. B., Eskilsson, A., Vasilache, A. M., Elander, L., Engblom, D., & Blomqvist, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.012 · Cited by 70
Paul, S., Shin, H. S., & Kang, S. C. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.02.035 · Cited by 71
Paracetamol versus placebo: Effects on post-operative course
Skjelbred, P., & L�kken, P. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00563555 · Cited by 66
Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?
Ishitsuka, Y., Kondo, Y., & Kadowaki, D. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00722 · Cited by 63
Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide
Taniguchi, Y., Yokoyama, K., Inui, K., Deguchi, Y., Furukawa, K., & Noda, K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00183-0 · Cited by 65
Serotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity
Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., & Talley, N. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00876.x · Cited by 64
Malmberg, A. B., & Yaksh, T. L. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90786-2 · Cited by 55
Reversal by naloxone of the spinal antinociceptive actions of a systemically‐administered NSAID
Herrero, J. F., & Headley, P. M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15494.x · Cited by 54
Carlsson, K. H., & Jurna, I. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90524-6 · Cited by 51
Rangasamy, S. B., Dasarathi, S., Pahan, P., Jana, M., & Pahan, K. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9808-3 · Cited by 49
“PD is known to have a prominent inflammatory component and we have demonstrated that selective inhibition of NF-κB activation by NEMO-binding peptides l e a d s t o p r o t e c t i o n o f t h e n i g r o s t r i a t um i n hemiparkinsonian mice (Ghosh et al. 2007) and monkey (Mondal et al. 2012).”
BackgroundInfluentialEffects of acetaminophen and antipyrine on non-inflammatory pain and EEG activity
Bromm, B., Forth, W., Richter, E., & Scharein, E. (1992) · Pain · doi:10.1016/0304-3959(92)90165-8 · Cited by 42
“In the case of the most important representative of this group, acetylsalicylic acid (aspirin), the well investigated inhibitory effect on prostaglandin biosynthesis has been assumed to explain the analgesic action (Vane 1971; Smith and Willis 1971; for review see Insel 1990).”
BackgroundZobdeh, F., Eremenko, I. I., Akan, M. A., Tarasov, V. V., Chubarev, V. N., Schiöth, H. B., & Mwinyi, J. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061190 · Cited by 45
“NSAIDs primarily inhibit COX-1 and COX-2, leading to analgesic, antipyretic, and anti-inflammatory effects [31].”
BackgroundReduction in cancer risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
Harris, R., Beebe, & Alshafie (2012) · Journal of Experimental Pharmacology · doi:10.2147/jep.s23826 · Cited by 43
Pharmacological hypotheses: Is acetaminophen selective in its cyclooxygenase inhibition?
Esh, C. J., Chrismas, B. C. R., Mauger, A. R., & Taylor, L. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.835 · Cited by 38
Cagnacci, A., Arangino, S., Tuveri, F., Paoletti, A. M., & Volpe, A. (2002) · Chronobiology International · doi:10.1081/cbi-120005394 · Cited by 37
Alternative strategies in cardiac preclinical research and new clinical trial formats
Kreutzer, F. P., Meinecke, A., Schmidt, K., Fiedler, J., & Thum, T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab075 · Cited by 36
The roles of prostaglandin E2 and D2 in lipopolysaccharide-mediated changes in sleep
Oishi, Y., Yoshida, K., Scammell, T. E., Urade, Y., Lazarus, M., & Saper, C. B. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.11.019 · Cited by 34
Effect of Aspirin and Acetaminophen on Proinflammatory Cytokine-Induced Pain Behavior in Mice
Kwon, M.-S., Shim, E.-J., Seo, Y.-J., Choi, S.-S., Lee, J.-Y., Lee, H.-K., & Suh, H.-W. (2005) · Pharmacology · doi:10.1159/000084548 · Cited by 31
Autophagy-mediated metabolic effects of aspirin
Castoldi, F., Humeau, J., Martins, I., Lachkar, S., Loew, D., Dingli, F., Durand, S., Enot, D., Bossut, N., Chery, A., et al. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00365-0 · Cited by 27
Microglia as a cellular target of diclofenac therapy in Alzheimer’s disease
Stopschinski, B. E., Weideman, R. A., McMahan, D., Jacob, D. A., Little, B. B., Chiang, H.-S., Saez Calveras, N., & Stuve, O. (2023) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864231156674 · Cited by 26
Crawford, I. L., Kennedy, J. I., Lipton, J. M., & Ojeda, S. R. (1979) · The Journal of Physiology · doi:10.1113/jphysiol.1979.sp012674 · Cited by 23
Marhuenda, J., Medina, S., Martínez-Hernández, P., Arina, S., Zafrilla, P., Mulero, J., Oger, C., Galano, J.-M., Durand, T., Solana, A., et al. (2017) · Food Funct. · doi:10.1039/c7fo01081h · Cited by 22
Blais, V., Zhang, J., & Rivest, S. (2002) · Endocrinology · doi:10.1210/en.2002-220598 · Cited by 22
“Since the classic work of Vane (17), it is widely accepted that the pharmacological action of NSAIDs is mediated by inhibiting the activity of COX.”
BackgroundAyoub, S. S., & Flower, R. J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172609 · Cited by 19
COUPAR, I. M., & TAYLOR, D. A. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09196.x · Cited by 19
Non-steroidal Anti-inflammatory Drugs and Pain
Appleton, I. (1997) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-60777-6_3 · Cited by 11
Chuang, M.-C., Yang, Y.-H., Hsieh, M.-J., Lin, Y.-C., Yang, T.-M., Chen, P.-C., & Hung, M.-S. (2021) · BMC Cancer · doi:10.1186/s12885-021-08999-8 · Cited by 9
“Notably, the anti-neoplastic effect of aspirin was mediated through its inhibition of COX enzymes that promote carcinogeneis through the synthesis of PG. [44] Apart from inhibiting the synthesis of PG, aspirin has also been shown to upregulate tumor-suppression genes and inhibit NF-kB activation, thus illustrating its…”
BackgroundInfluentialNon steroidal antiinflammatory drugs may be harmful to normal kidneys: experimental surgery model*.
(2012) · Europe PMC (PubMed Central) · Cited by 6
Metadata
- Authors
- VANE, J. R.
- Affiliations
- Royal College of Surgeons of England (GB)
- Corresponding author
- VANE, J. R.
- Venue
- Nature New Biology
- Published
- 1971-06
- Volume
- 231
- Issue
- 25
- Pages
- 232-235
- ISSN
- 0090-0028 (ISSN-L)
- 2058-1092
- OpenAlex
- W2008574207
- Cited by
- 8,605
- References
- 26
- Citations by year
- 2026: 51 · 2025: 72 · 2024: 86 · 2023: 106 · 2022: 117 · 2021: 121 · 2020: 118 · 2019: 114 · 2018: 123 · 2017: 150 · 2016: 144 · 2015: 154 · 2014: 154 · 2013: 162 · 2012: 190
- FWCI
- 183.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature New Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- aspirin, salicylates, prostaglandin synthesis inhibition, mechanism of action, guinea pig lung, anti-inflammatory agents
- MeSH terms
- Animals, Arachidonic Acids, Aspirin, Biological Assay, Chromatography, Thin Layer, Colon, Guinea Pigs, Indomethacin, Lung, Prostaglandins, Salicylates, Stomach, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.